Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

Discussing the ongoing Karyopharm Therapeutics' SENTRY trial Evaluating Selinexor in Combination with Ruxolitinib in JAKi-Naive Myelofibrosis patients

Executed on:Feb 25, 2026 4:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Mount Sinai
  • Assistant Professor at the Mount Sinai Health System (Icahn School of Medicine).
  • Manages 40-50 patients with MF currently and is familiar with the MOMENTUM trial.
  • Research interests include myeloproliferative neoplasms, especially polycythemia vera and myelofibrosis, as well as acute myeloid leukemia, hemophagocytic lymphohistiocytosis, systemic mastocytosis, and chronic myelomonocytic leukemia and has published extensively on these topics.

Interview Goal

Discussing the outlook for the SENTRY trial from Karyopharm Therapeutics

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.